Balyasny Asset Management LLC Design Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.99 - $7.64 $92,310 - $141,332	18,499 New	18,499 $116,000
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $156,878 - $284,696	11,134 New	11,134 $186,000
Q2 2021 Aug 16, 2021	SELL	$19.02 - $29.78 $822,615 - $1.29 Million	-43,250 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.52 - $41.49 $1.28 Million - $1.79 Million	43,250 New	43,250 $1.29 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.